or Try an Advanced Search...

    Therapies For Cancer Stocks List

    Symbol Grade Name % Change
    GALT C Galectin Therapeutics Inc. -2.31
    VOR D Vor Biopharma Inc. -1.11
    PMCB F PharmaCyte Biotech, Inc. 4.65
    ARTV F Artiva Biotherapeutics, Inc. 3.24
    CRGX F CARGO Therapeutics, Inc. -0.44
    CGEM F Cullinan Management, Inc. -2.70
    BDTX F Black Diamond Therapeutics, Inc. -0.21
    NKTX F Nkarta, Inc. -2.20
    ALLO F Allogene Therapeutics, Inc. 3.17
    ACET F Adicet Bio, Inc. -5.31
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Biotechnology Immune System Tumor Antigen Cancer Immunotherapy Medicine Acute Myeloid Leukemia Adoptive Cell Transfer Antibodies Biopharmaceutical Cancer Treatment Cell Therapy Chimeric Antigen Receptor Chimeric Antigen Receptor T Cell Clinical Medicine Gene Therapy Tyrosine Kinase Receptors Alcohol Biology

    Related ETFs - A few ETFs which own one or more of the above listed Therapies For Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 4.52
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.32
    MEDX F Horizon Kinetics Medical ETF 1.17
    CANC D Tema Oncology ETF 0.83
    GNOM F Global X Genomics & Biotechnology ETF 0.79
    View all Therapies For Cancer ETFs...
    Compare ETFs
    Compare BBC to CANC Compare CNCR to BBC Compare MEDX to GNOM

        Therapies For Cancer Stocks Recent News

        Date Stock Title
        Nov 19 ALLO Allogene Therapeutics Announces Participation in December Investor Conferences
        Nov 18 ACET Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
        Nov 18 ALLO Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence
        Nov 18 GALT Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
        Nov 18 ACET Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
        Nov 18 ACET Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans?
        Nov 16 ACET Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Biotechnology Immune System Tumor Antigen Cancer Immunotherapy Medicine Acute Myeloid Leukemia Adoptive Cell Transfer Antibodies Biopharmaceutical Cancer Treatment Cell Therapy Chimeric Antigen Receptor Chimeric Antigen Receptor T Cell Clinical Medicine Gene Therapy Tyrosine Kinase Receptors Alcohol Biology
        Therapies For Cancer

        Therapies for cancer can include a variety of treatments, such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Depending on the type and stage of cancer, a combination of these treatments may be used. Other treatments, such as hormone therapy, stem cell transplantation, and cryotherapy, may also be used.

        Browse All Tags